| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0083 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |